Mitotane

Test information: The adrenolytic agent Mitotane (o,p'-DDD) has been in use since 1960 and is licensed for use in the treatment of inoperable adrenocortical carcinoma. Its cytostatic effect appears to depend on the maintenance of adequate plasma levels, and encouraging results have been achieved when drug dosing has been based on pharmacological monitoring.

Specimen Type(s)

• Blood;

Other Acceptable Specimen Type(s)

N/A

Specimen Container - Adult

• Purple Top BD;

Specimen Container - Paediatric

• Lilac Top Microtainer BD;

Analytes

• N/A;

Part of a test profile?

N/A

Volume (min) of sample to be sent to laboratory

1ml

Patient Preparation, Sample Handling and Transport

Trough sample.

Maximum add on time

N/A

Units and Reference Ranges / Interpretation

Please see the report.

UKAS number

8989

UKAS accredited test?

Yes

Comments

N/A

If you have any queries about a test or results interpretation please contact us.